Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study
Top Cited Papers
- 2 August 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 112 (5) , 666-673
- https://doi.org/10.1161/circulationaha.104.516948
Abstract
Background— Different definitions of the metabolic syndrome have been proposed. Their value in a clinical setting to assess cardiovascular disease (CVD) risk is still unclear. We compared the definitions proposed by the National Cholesterol Education Program Adult Treatment Panel III (NCEP), World Health Organization (WHO), European Group for the Study of Insulin Resistance (EGIR), and American College of Endocrinology (ACE) with respect to the prevalence of the metabolic syndrome and the association with 10-year risk of fatal and nonfatal CVD. Methods and Results— The Hoorn Study is a population-based cohort study. The present study population comprised 615 men and 749 women aged 50 to 75 years and without diabetes or a history of CVD at baseline in 1989 to 1990. The prevalence of the metabolic syndrome at baseline ranged from 17% to 32%. The NCEP definition was associated with about a 2-fold increase in age-adjusted risk of fatal CVD in men and nonfatal CVD in women. For the WHO, EGIR, and ACE definitions, these hazard ratios were slightly lower. Risk increased with the number of risk factors. Elevated insulin levels were more prevalent in subjects with multiple risk factors, but metabolic syndrome definitions including elevated insulin level were not more strongly associated with risk. Conclusions— The metabolic syndrome, however defined, is associated with an approximate 2-fold increased risk of incident cardiovascular morbidity and mortality in a European population. In clinical practice, a more informative assessment can be obtained by taking into account the number of individual risk factors.Keywords
This publication has 32 references indexed in Scilit:
- Measures of Insulin Resistance Add Incremental Value to the Clinical Diagnosis of Metabolic Syndrome in Association With Coronary AtherosclerosisCirculation, 2004
- C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring StudyCirculation, 2004
- Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and WomenArchives of internal medicine (1960), 2004
- The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality StudyAtherosclerosis, 2004
- Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disordersAtherosclerosis, 2004
- Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectPublished by Oxford University Press (OUP) ,2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Comment on the provisional report from the WHO consultationDiabetic Medicine, 1999
- Microalbuminuria and Peripheral Arterial Disease Are Independent Predictors of Cardiovascular and All-Cause Mortality, Especially Among Hypertensive SubjectsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).Journal of Clinical Investigation, 1997